Description
Cinnarizin-OZ (Cinnarizinum) Tablets 0.025 №50
Composition
Active ingredient: Cinnarizinum 0.025mg per tablet.
Mechanism of Action
Pharmacological Properties: Cinnarizine acts by inhibiting the entry of calcium ions into smooth muscle cells, thereby preventing the constriction of blood vessels in the inner ear. This mechanism helps to improve blood flow and reduce symptoms of vertigo and dizziness.
Indications for Use
Indications: Cinnarizin-OZ tablets are indicated for the treatment of vertigo, Meniere’s disease, and motion sickness.
Contraindications
Contraindications: Do not use Cinnarizin-OZ tablets if you are allergic to cinnarizine or any other ingredients in the product. Consult your doctor before use if you are pregnant or breastfeeding.
Side Effects
Side Effects: Common side effects include drowsiness and dry mouth. It is important to follow the recommended dosage and not exceed the prescribed amount to avoid adverse effects.
Usage Instructions
Directions: Swallow the tablet whole with a glass of water. Do not crush or chew the tablet. The usual dose is 1 tablet taken 2-3 times daily with meals.
Benefits Compared to Analogues
Cinnarizin-OZ tablets have shown efficacy in reducing the frequency and severity of vertigo attacks in patients with Meniere’s disease, making it a valuable treatment option compared to other medications.
Suitable Patient Groups
Cinnarizin-OZ tablets are suitable for adults of all ages. However, special caution should be exercised when administering to children, pregnant women, and the elderly. Consult a healthcare professional for appropriate dosage adjustments.
Storage and Packaging
Storage Conditions: Store in a cool, dry place away from direct sunlight. Keep out of reach of children.
Shelf Life: Check the expiration date on the packaging. Do not use the product after the expiration date.
Packaging Description: Each package contains 50 tablets of Cinnarizin-OZ (Cinnarizinum) 0.025mg.
Clinical Evidence and Effectiveness
Clinical Trials: A randomized controlled trial published in the Journal of Otolaryngology – Head & Neck Surgery demonstrated the efficacy of cinnarizine in reducing vertigo attacks and improving quality of life in patients with Meniere’s disease. The study concluded that cinnarizine is a safe and effective treatment option for vertigo associated with inner ear disorders.
